SHERIANN ROLLINS: Open Payments
NPI 1750312054 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 22 payments from 10 companies in 2025. Trend: 2023 $448 · 2024 $480 · 2025 $610
Food & beverage: $610
| Company | Payments | Amount |
|---|---|---|
| BIOTRONIK NRO, Inc. | 7 | $284 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $58 |
| Averitas Pharma Inc. | 2 | $46 |
| Medtronic, Inc. | 2 | $44 |
| Saluda Medical Americas, Inc. | 2 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Merz Pharmaceuticals, LLC | 1 | $32 |
| Boston Scientific Corporation | 1 | $23 |
| ABBVIE INC. | 1 | $22 |
| SPR Therapeutics, Inc | 1 | $22 |
Products named: Prospera, JOURNAVX, QUTENZA, INCEPTIV, Evoke, RELISTOR, Xeomin, General - Therapies.
Industry payments across UT — which companies pay providers there.
